1. September 29, 2020

    Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

    Source: FAMHP

    On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.

    Read more

  2. September 29, 2020

    Give your opinion on a genetically modified drug for the treatment of Duchenne muscular dystrophy

    Source: FAMHP

    The FPS Public Health and FAMHP would like to invite you to take part in the public consultation on a clinical trial testing the genetically modified drug PF-06939926 for the treatment of Duchenne muscular dystrophy. The public consultation will run from 23 September 2020 to 23 October 2020.

    Read more

  3. September 29, 2020

    Coronavirus: at-home antibody tests are no longer banned, but the FAMHP warns against misinterpreting the result

    Source: FAMHP

    The sale of at-home tests detecting antibodies against the new coronavirus (SARS-CoV-2) will no longer be prohibited as of 19 September 2020. However, the FAMHP warns users that there are still significant reservations about the accuracy of both negative and positive results. These at-home tests may give users a false sense of security or cause them unnecessary anxiety.

    Read more

  4. September 18, 2020

    New edition VIG-news available

    Source: FAMHP

    Nieuwe editie VIG-news beschikbaar.

    Nouvelle édition VIG-news disponible. 

    Read more

  5. September 18, 2020

    PRAC September 2020 – Revocation of marketing authorisation of ulipristal acetate (Esmya) for uterine fibroids

    Source: FAMHP

    During its meeting of September 2020, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) recommended the revocation of marketing authorisation of ulipristal acetate for uterine fibroids.

    Read more

  6. September 18, 2020

    Gardasil, vaccine against HPV (Human Papillomaviruses), is available again

    Source: FAMHP

    After a period of limited availability, the Gardasil 9 vaccine, used to prevent Human Papillomaviruses (HPV), is available to everyone again.

    Read more

  7. September 8, 2020

    Coronavirus - Consultation between the FAMHP and the clinical laboratories on serological tests COVID-19

    Source: FAMHP

    Coronavirus - Overleg tussen het FAGG en de klinische labo's over de serologische tests COVID-19

    Coronavirus – Concertation entre l’AFMPS et les laboratoires cliniques quant aux tests sérologiques COVID-19

    Read more

  8. September 7, 2020

    Healixia traject - Let's connect

    Whenever and wherever

    We have worked out a traject of multiple online events. 

    Read more

  9. August 31, 2020

    Nitrosamines in medicinal products: deadlines for submitting risk assessments, the results of confirmatory tests and the MA adaptation

    Source: FAMHP

    Early October 2019, the European Medicines Agency (EMA), together with the European medicines authorities, including the FAMHP, asked all marketing authorisation holders to perform a risk assessment on the presence of nitrosamines as a precaution.

    Read more

  10. August 31, 2020

    Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

    Source: FAMHP

    On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.

    Read more